DK1284993T3 - Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater - Google Patents

Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater

Info

Publication number
DK1284993T3
DK1284993T3 DK01945261T DK01945261T DK1284993T3 DK 1284993 T3 DK1284993 T3 DK 1284993T3 DK 01945261 T DK01945261 T DK 01945261T DK 01945261 T DK01945261 T DK 01945261T DK 1284993 T3 DK1284993 T3 DK 1284993T3
Authority
DK
Denmark
Prior art keywords
bordetella
pertactin
parapertussis
bronchiseptica
pertussis
Prior art date
Application number
DK01945261T
Other languages
English (en)
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1284993T3 publication Critical patent/DK1284993T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01945261T 2000-05-25 2001-05-23 Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater DK1284993T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Publications (1)

Publication Number Publication Date
DK1284993T3 true DK1284993T3 (da) 2008-07-28

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945261T DK1284993T3 (da) 2000-05-25 2001-05-23 Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater

Country Status (11)

Country Link
US (3) US7070779B2 (da)
EP (1) EP1284993B1 (da)
JP (1) JP2003533990A (da)
AT (1) ATE393166T1 (da)
AU (1) AU2001267527A1 (da)
CY (1) CY1110430T1 (da)
DE (1) DE60133734T2 (da)
DK (1) DK1284993T3 (da)
ES (1) ES2303833T3 (da)
PT (1) PT1284993E (da)
WO (1) WO2001090143A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
ES2303833T3 (es) 2000-05-25 2008-09-01 Institut Pasteur Polipeptidos que contienen polimorfismos de las regiones repetidas de pertactina en bordetella pertussis, bordetella parapertussis y bordetella bronchiseptica, su uso en diagnostico y en composiciones inmunogenicas.
CN101795706B (zh) 2007-05-28 2014-12-03 北里第一三共疫苗股份有限公司 副百日咳杆菌全菌体疫苗组合物
CU23679A1 (es) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
MX347177B (es) * 2011-02-04 2017-04-17 Zoetis Services Llc Composiciones inmunogenas de bordetella bronchiseptica.
BR112013019850B1 (pt) * 2011-02-04 2023-02-28 Zoetis Services Llc Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
ES2303833T3 (es) 2000-05-25 2008-09-01 Institut Pasteur Polipeptidos que contienen polimorfismos de las regiones repetidas de pertactina en bordetella pertussis, bordetella parapertussis y bordetella bronchiseptica, su uso en diagnostico y en composiciones inmunogenicas.

Also Published As

Publication number Publication date
EP1284993B1 (en) 2008-04-23
US20060008474A1 (en) 2006-01-12
JP2003533990A (ja) 2003-11-18
DE60133734D1 (de) 2008-06-05
ATE393166T1 (de) 2008-05-15
ES2303833T3 (es) 2008-09-01
CY1110430T1 (el) 2012-05-23
DE60133734T2 (de) 2009-05-14
US7070779B2 (en) 2006-07-04
US6964767B2 (en) 2005-11-15
US7314910B2 (en) 2008-01-01
WO2001090143A2 (en) 2001-11-29
US20040166116A9 (en) 2004-08-26
WO2001090143A3 (en) 2002-09-26
US20030180307A1 (en) 2003-09-25
US20020192237A1 (en) 2002-12-19
PT1284993E (pt) 2008-06-11
AU2001267527A1 (en) 2001-12-03
EP1284993A2 (en) 2003-02-26

Similar Documents

Publication Publication Date Title
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
HU9904549A (en) Vaccines
ATE263157T1 (de) Nematizide trifluorbutene
DK1335728T3 (da) Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
HRP20041085B1 (hr) Inhibitori hepatitis c virusa
DK1542732T3 (da) Fusionsproteiner af Mycobacterium tuberculosis
MY138326A (en) Process for the preparation of alkylene glycols
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DK0766696T3 (da) Thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
HUP0303126A2 (hu) Vektorok molekuláknak CD11b-t expresszáló sejtekhez történő szállítására
DK1159968T3 (da) Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning
DE60132427D1 (de) Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
BR0016971A (pt) Método aperfeiçoado para ansiedade
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
DK0413667T3 (da) Halogenalkylphenyl-alkoholer, ketoner og hydrater deraf
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
DE60120120D1 (de) Beutelformzusammensetzungen
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
AR029468A1 (es) Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
DK0787796T3 (da) Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner